These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28919617)

  • 1. Response & Side Effects of Injectable Labetalol in Pregnancy Induced Severe Hypertension.
    Akter FA; Nahar K; Rahman MM; Ferdousi RA; Ahmed MU; Begum F; Biswas D; Alom M; Hossain MZ; Razi RZ
    Mymensingh Med J; 2017 Jul; 26(3):608-613. PubMed ID: 28919617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial.
    Shekhar S; Sharma C; Thakur S; Verma S
    Obstet Gynecol; 2013 Nov; 122(5):1057-1063. PubMed ID: 24104790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure.
    Tolcher MC; Fox KA; Sangi-Haghpeykar H; Clark SL; Belfort MA
    Am J Obstet Gynecol; 2020 Sep; 223(3):441.e1-441.e8. PubMed ID: 32544404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
    Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.
    Raheem IA; Saaid R; Omar SZ; Tan PC
    BJOG; 2012 Jan; 119(1):78-85. PubMed ID: 21985500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.
    Chera-Aree P; Tengtrakulcharoen P; Leetheeragul J; Sampaojarean U; Surasereewong S; Wataganara T
    J Clin Pharmacol; 2020 Dec; 60(12):1662-1670. PubMed ID: 32598488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labetalol Versus Nifedipine as Antihypertensive Treatment for Chronic Hypertension in Pregnancy: A Randomized Controlled Trial.
    Webster LM; Myers JE; Nelson-Piercy C; Harding K; Cruickshank JK; Watt-Coote I; Khalil A; Wiesender C; Seed PT; Chappell LC
    Hypertension; 2017 Nov; 70(5):915-922. PubMed ID: 28893900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial.
    Zulfeen M; Tatapudi R; Sowjanya R
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():46-52. PubMed ID: 30878897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse pressure as a predictor of response to treatment for severe hypertension in pregnancy.
    Mullan SJ; Vricella LK; Edwards AM; Powel JE; Ong SK; Li X; Tomlinson TM
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100455. PubMed ID: 34375751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy.
    Vermillion ST; Scardo JA; Newman RB; Chauhan SP
    Am J Obstet Gynecol; 1999 Oct; 181(4):858-61. PubMed ID: 10521742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension.
    Kilpatrick SJ; Abreo A; Greene N; Melsop K; Peterson N; Shields LE; Main EK
    Am J Obstet Gynecol; 2016 Jul; 215(1):91.e1-7. PubMed ID: 26829504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
    Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
    Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
    Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
    Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokinetic-dynamic analysis.
    Saotome T; Minoura S; Terashi K; Sato T; Echizen H; Ishizaki T
    J Clin Pharmacol; 1993 Oct; 33(10):979-88. PubMed ID: 8227470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
    Gonzalez ER; Peterson MA; Racht EM; Ornato JP; Due DL
    Ann Emerg Med; 1991 Apr; 20(4):333-8. PubMed ID: 2003657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
    Gaynor MF; Wright GC; Vondracek S
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
    Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
    Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Nifedipine and Labetalol Combined with Magnesium Sulfate on Blood Pressure Control, Blood Coagulation Function, and Maternal and Infant Outcome in Patients with Pregnancy-Induced Hypertension.
    Shao Y; Gu S; Zhang X
    Comput Math Methods Med; 2022; 2022():9317114. PubMed ID: 36277012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To study the changes in maternal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension.
    Thakur M; Gainder S; Saha SC; Prakash M
    Pregnancy Hypertens; 2020 Jul; 21():180-183. PubMed ID: 32570152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal haemodynamic effects following foetal exposure to labetalol in hypertensive disorders of pregnancy.
    Thewissen L; Pistorius L; Baerts W; Naulaers G; Van Bel F; Lemmers P
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1533-1538. PubMed ID: 27294851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.